Literature DB >> 10088610

LPS down-regulates the expression of chemokine receptor CCR2 in mice and abolishes macrophage infiltration in acute inflammation.

Y Zhou1, Y Yang, G Warr, R Bravo.   

Abstract

Interactions between chemokines and their specific receptors are important for leukocyte trafficking. The CC-chemokine monocyte chemoattractant protein-1 (MCP-1) and its specific receptor CCR2 are essential in monocytic infiltration and have been associated with several inflammatory diseases. It has been reported that several endotoxin and proinflammatory cytokines inhibit CCR2 expression in vitro in human monocytes. We report here that lipopolysaccharides (LPS) down-regulated CCR2 expression both in vitro and in vivo. Injection of LPS into mice dramatically reduced the expression of CCR2 on the surface of peripheral blood cells and completely blocked macrophage infiltration into the peritoneal cavity in response to thioglycollate elicitation. In addition, treatment of mice with LPS reduced their efficiency to clear Listeria monocytogenes infection. These results suggest that down-regulation of CCR2 and blockage of monocyte infiltration may contribute to the inhibition of macrophage function in vivo by a low dose of LPS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088610     DOI: 10.1002/jlb.65.2.265

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

Review 1.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals.

Authors:  G Wang; K O
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

3.  Murine macrophage response from peritoneal cavity requires signals mediated by chemokine receptor CCR-2 during Staphylococcus aureus infection.

Authors:  Ajeya Nandi; Biswadev Bishayi
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 4.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

5.  An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

Authors:  Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

6.  Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis.

Authors:  Erwin Gäbele; Marcus Mühlbauer; Hartwig Paulo; Monika Johann; Christin Meltzer; Franz Leidl; Norbert Wodarz; Reiner Wiest; Jürgen Schölmerich; Claus Hellerbrand
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

7.  TLR4 Signaling augments monocyte chemotaxis by regulating G protein-coupled receptor kinase 2 translocation.

Authors:  Zheng Liu; Yong Jiang; Yuehua Li; Juan Wang; Liyan Fan; Melanie J Scott; Guozhi Xiao; Song Li; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

8.  Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.

Authors:  Myriam Aouadi; Gregory J Tesz; Sarah M Nicoloro; Mengxi Wang; My Chouinard; Ernesto Soto; Gary R Ostroff; Michael P Czech
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

9.  Matrine Inhibits Infiltration of the Inflammatory Gr1(hi) Monocyte Subset in Injured Mouse Liver through Inhibition of Monocyte Chemoattractant Protein-1.

Authors:  Duo Shi; Jinjin Zhang; Lei Qiu; Jianzhong Li; Zhenlin Hu; Junping Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-22       Impact factor: 2.629

10.  Norepinephrine inhibits macrophage migration by decreasing CCR2 expression.

Authors:  Fangming Xiu; Mile Stanojcic; Marc G Jeschke
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.